Open Access

SGLT2 inhibitors in practice: what are the next steps?

Topic: Chronic Heart Failure, Other
Sponsored by Boehringer Ingelheim & Eli Lilly

Congress Presentation

About the speaker

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)
114 presentations
4 followers

4 more presentations in this session

Introduction and recap.

Speaker: Professor J. Butler (Jackson, US)

Thumbnail

What is the evidence for SGLT2 inhibitors in HF?

Speaker: Professor P. Ponikowski (Wroclaw, PL)

Thumbnail

Implementing in-hospital initiation of an SGLT2 inhibitor in my practice.

Speaker: Doctor M. Costanzo (Naperville, US)

Thumbnail

Panel discussion.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Access the full session

SGLT2 inhibitors in practice (part 4): initiating heart failure treatment in hospital

Speakers: Professor S. Anker, Professor J. Butler, Professor P. Ponikowski, Doctor M. Costanzo, Professor S. Anker
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk